Close
Back to CHRS Stock Lookup

Coherus BioSciences (CHRS) – Analyst EPS View

Aug 8, 2017 09:07 AM Coherus Biosciences (CHRS) PT Lowered to $38 at BMO Capital; 'Refiling of Neulasta Biosimilar Remains on Track for 4Q17'
Jun 14, 2017 09:10 AM Coherus Biosciences (CHRS) PT Lowered to $24 at Credit Suisse; Neulasta Biosimilar CRL Poses Greater Risk for CHS-1701
Jun 12, 2017 12:03 PM
Sep 6, 2016 05:07 PM
Dec 2, 2014 01:24 PM

Back to CHRS Stock Lookup